KEYNOTE-158: Pembrolizumab Use in Advanced Endometrial Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
KEYNOTE-158: Pembrolizumab Use in Advanced Endometrial Cancer …
Mar 1, 2022
targetedonc.com
KEYNOTE-826: Pembrolizumab Plus Chemotherapy in Advanced Cervical Cancer
KEYNOTE-826: Pembrolizumab Plus Chemotherapy in Advanced Cervi…
Sep 19, 2021
ascopost.com
KEYNOTE-775: Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer | OncLive
KEYNOTE-775: Lenvatinib Plus Pembrolizumab in Advanced Endo…
Aug 3, 2023
onclive.com
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNBC | OncLive
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNB…
Jun 1, 2022
onclive.com
KEYNOTE-091 Evaluates Adjuvant Pembrolizumab in Resected Early-Stage NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
KEYNOTE-091 Evaluates Adjuvant Pembrolizumab in Resected Early …
Jul 19, 2022
targetedonc.com
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSCC at AACR 2025
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSC…
Apr 29, 2025
oncologytube.com
KEYNOTE-756: Pembrolizumab Plus Chemo in Early-Stage ER /HER2- Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
KEYNOTE-756: Pembrolizumab Plus Chemo in Early-Stage ER /HER2- …
Nov 9, 2023
targetedonc.com
KEYNOTE-811: Clinical Outcomes and Safety of Pembrolizumab Tras…
5 months ago
targetedonc.com
Makoto Tahara, ESMO 2022: 5-year results from KEYNOTE-048 - Pem…
20 viewsSep 14, 2022
touchoncology.com
Dr Luke on Results of KEYNOTE-716 of Adjuvant Pembrolizumab in Sta…
Jun 6, 2023
onclive.com
14:04
EV-302/KEYNOTE-A39: Open-Label, Randomized Phase 3 Study of Enf…
Oct 31, 2023
onclive.com
4:11
Dr Schmid on the Use of Perioperative Pembrolizumab in T…
Dec 8, 2023
onclive.com
1:17
Dr Shah on 5-Year Outcomes With Pembrolizumab/Chemo in Esopha…
Apr 5, 2024
onclive.com
5:36
Final OS Data for Pembrolizumab Plus Trastuzumab/Chemotherapy i…
Oct 28, 2024
onclive.com
2:57
2026 ASCO GU Highlights: Bladder Cancer KEYNOTE-B15 | Targeted …
3 months ago
targetedonc.com
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head …
Aug 20, 2020
onclive.com
Dr Oselin on a Subgroup Analysis of the PEARLS/KEYNOTE-091 Trial i…
Jun 26, 2023
onclive.com
3:01
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer
6.8K viewsJul 2, 2018
YouTubeTargeted Oncology
2:05
Pembrolizumab as Second-line Therapy for Advanced Urothelial C…
11.5K viewsMar 16, 2017
YouTubeNEJM Group
1:23
3-Year Update Shows Continued Efficacy of Pembrolizumab for Mel…
171 viewsJun 16, 2020
YouTubeTargeted Oncology
8:19
KEYNOTE Trial Data: Pembrolizumab’s Role in NSCLC
261 viewsJul 23, 2018
YouTubeOncLive
0:56
Pembrolizumab as adjuvant therapy for TNBC
2K viewsSep 16, 2022
YouTubeVJOncology
3:28
KEYNOTE-775 subgroup analysis in advanced endometrial cancer
767 viewsOct 14, 2021
YouTubeVJOncology
5:42
KEYNOTE-189: Chemotherapy and Pembrolizumab in mNSCLC
809 viewsJul 11, 2018
YouTubeOncLive
1:22
Dr. Weber on Adjuvant Pembrolizumab in Melanoma
446 viewsNov 22, 2019
YouTubeOncLive
3:24
Pembro +/- ipi in metastatic NSCLC: KEYNOTE-598
147 viewsFeb 8, 2021
YouTubeVJOncology
1:38
Dr. Mok Discusses Next Steps for Pembrolizumab in NSCLC
413 viewsMay 7, 2019
YouTubeTargeted Oncology
1:14
KEYNOTE-A18: pembrolizumab with chemoradiotherapy for advanced …
512 viewsOct 25, 2023
YouTubeVJOncology
2:23
Pembrolizumab plus chemotherapy for esophageal cancer: KEYNOTE …
1.7K viewsSep 29, 2020
YouTubeVJOncology
4:47
Benefit of Pembrolizumab in NSCLC: The KEYNOTE Trials
82 viewsAug 28, 2018
YouTubeTargeted Oncology
See more videos
Static thumbnail place holder